Sign in
4

Changes in Ownership

Bicara Therapeutics Inc. Filed Acc 0001470831-26-000813

Chief Executive Officer sold 10,000 shares at $27.98 ($279,750)

  • Chief Executive Officer acquired 10,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Mazumdar Claire · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-08-10 Exercise or conversion : show line 1 in the form 10b5-1 +10,000 $3.79 $37,898 372,152 D
2026-08-10 Sale : show line 2 in the form 10b5-1 −10,000 $27.98 $279,750 362,152 D
Open-market sales · 10,000 sh · avg $27.98 · $279,750

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-08-10 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) −10,000 110,546 D
Loading xslF345X06/wk-form4_1786565953.xml…